Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Shire Pharmaceuticals Limited
Hampshire International Business Park, Chineham, Basingstoke, Hampshire , RG24 8EP
Telephone: +44 (0)1256 894 000
WWW: http://www.shire.com
Medical Information Direct Line: 0800 055 6614
Medical Information e-mail: medinfoUK@shire.com
Customer Care direct line: +44 (0)1256 894 107

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 06/06/2011
PIL Xagrid 0.5mg hard capsule

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 06/06/2011 and displayed until Current
Reasons for adding or updating:
  • Change to Further Information section
Updated on 17/05/2011 and displayed until 06/06/2011
Reasons for adding or updating:
  • Change to drug interactions
Updated on 28/02/2011 and displayed until 17/05/2011
Reasons for adding or updating:
  • Change to Further Information section
  • Correction of spelling/typing errors
  • Change to manufacturer contact details
Updated on 08/12/2010 and displayed until 28/02/2011
Reasons for adding or updating:
  • Removal/change of distributor
  • Correction of spelling/typing errors
  • Change to side-effects
Updated on 25/05/2010 and displayed until 08/12/2010
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to side-effects
Updated on 19/01/2010 and displayed until 25/05/2010
Reasons for adding or updating:
  • Removal/change of distributor
  • Change to date of revision
Updated on 10/11/2009 and displayed until 19/01/2010
Reasons for adding or updating:
  • Change to date of revision
  • Correction of spelling/typing errors
  • Change of contra-indications
  • Change to side-effects
  • Change to information about driving or using machinery
  • Change to dosage and administration
  • Change to MA holder contact details
Updated on 06/03/2009 and displayed until 10/11/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to MA holder contact details
Updated on 16/12/2008 and displayed until 06/03/2009
Reasons for adding or updating:
  • Change to Further Information section
Updated on 15/10/2008 and displayed until 16/12/2008
Reasons for adding or updating:
  • Change to Further Information section
Updated on 10/06/2008 and displayed until 15/10/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 04/02/2008 and displayed until 10/06/2008
Reasons for adding or updating:
  • Extra statutory information
Updated on 07/06/2007 and displayed until 04/02/2008
Reasons for adding or updating:
  • Change to side-effects
  • Change to Further Information section
Updated on 27/09/2006 and displayed until 07/06/2007
Reasons for adding or updating:
  • Change of contra-indications
  • Change to side-effects
  • Change to Further Information section
  • Change to date of revision
Updated on 14/03/2006 and displayed until 27/09/2006
Reasons for adding or updating:
  • Change to side-effects
  • Change to Further Information section
  • Change to date of revision
Updated on 31/01/2005 and displayed until 14/03/2006
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  anagrelide hydrochloride